Patents by Inventor Robert E. Dudley

Robert E. Dudley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240156836
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone undecanoate are provided.
    Type: Application
    Filed: August 17, 2023
    Publication date: May 16, 2024
    Inventors: Robert E. Dudley, Theodore Danoff, James A. Longstreth
  • Publication number: 20230233578
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. In some embodiments, the subject has adequately controlled blood pressure.
    Type: Application
    Filed: February 21, 2023
    Publication date: July 27, 2023
    Inventors: Robert E. Dudley, Theodore Danoff
  • Publication number: 20230218635
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. In some embodiments, the subject has adequately controlled blood pressure.
    Type: Application
    Filed: December 22, 2022
    Publication date: July 13, 2023
    Inventors: Robert E. Dudley, Theodore Danoff
  • Publication number: 20230165878
    Abstract: A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
    Type: Application
    Filed: November 22, 2022
    Publication date: June 1, 2023
    Inventors: Robert E. Dudley, Panayiotis P. Constantinides
  • Publication number: 20230105163
    Abstract: A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.
    Type: Application
    Filed: July 22, 2022
    Publication date: April 6, 2023
    Inventors: Robert E. DUDLEY, Panayiotis P. CONSTANTINIDES
  • Patent number: 11564933
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. In some embodiments, the subject has adequately controlled blood pressure.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: January 31, 2023
    Assignee: Tolmar, Inc.
    Inventors: Robert E. Dudley, Theodore Danoff
  • Patent number: 11426416
    Abstract: A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: August 30, 2022
    Assignee: Clarus Therapeutics, Inc.
    Inventors: Robert E. Dudley, Panayiotis P. Constantinides
  • Patent number: 11331325
    Abstract: A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: May 17, 2022
    Assignee: Clarus Therapeutics, Inc.
    Inventors: Robert E. Dudley, Panayiotis P. Constantinides
  • Publication number: 20220088034
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone undecanoate are provided.
    Type: Application
    Filed: April 20, 2021
    Publication date: March 24, 2022
    Inventors: Robert E. DUDLEY, Theodore DANOFF, James A. LONGSTRETH
  • Patent number: 11179402
    Abstract: A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: November 23, 2021
    Assignee: Clarus Therapeutics, Inc.
    Inventors: Robert E. Dudley, Panayiotis P. Constantinides
  • Patent number: 11179403
    Abstract: A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: November 23, 2021
    Assignee: Clarus Therapeutics, Inc.
    Inventors: Robert E. Dudley, Panayiotis P. Constantinides
  • Publication number: 20210220374
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed to provide optimum serum testosterone levels over an extended period.
    Type: Application
    Filed: August 24, 2020
    Publication date: July 22, 2021
    Inventors: Robert E. DUDLEY, Panayiotis P. CONSTANTINIDES, James A. LONGSTRETH
  • Publication number: 20200323880
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. In some embodiments, the subject has adequately controlled blood pressure.
    Type: Application
    Filed: April 12, 2019
    Publication date: October 15, 2020
    Inventors: Robert E. DUDLEY, Theodore DANOFF
  • Publication number: 20200197412
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone undecanoate are provided.
    Type: Application
    Filed: December 19, 2019
    Publication date: June 25, 2020
    Inventors: Robert E. DUDLEY, Theodore DANOFF, James A. LONGSTRETH
  • Publication number: 20200197413
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone undecanoate are provided.
    Type: Application
    Filed: December 19, 2019
    Publication date: June 25, 2020
    Inventors: Robert E. DUDLEY, Theodore DANOFF, James A. LONGSTRETH
  • Patent number: 10617696
    Abstract: A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: April 14, 2020
    Assignee: Clarus Therapeutics, Inc.
    Inventors: Robert E. Dudley, Panayiotis P. Constantinides
  • Publication number: 20200093836
    Abstract: A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.
    Type: Application
    Filed: October 17, 2019
    Publication date: March 26, 2020
    Inventors: Robert E. DUDLEY, Panayiotis P. CONSTANTINIDES
  • Publication number: 20200054648
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed to provide optimum serum testosterone levels over an extended period.
    Type: Application
    Filed: March 21, 2019
    Publication date: February 20, 2020
    Inventors: Robert E. DUDLEY, Panayiotis P. CONSTANTINIDES, James A. LONGSTRETH
  • Publication number: 20200046733
    Abstract: A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
    Type: Application
    Filed: October 17, 2019
    Publication date: February 13, 2020
    Inventors: Robert E. DUDLEY, Panayiotis P. CONSTANTINIDES
  • Publication number: 20200046732
    Abstract: A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.
    Type: Application
    Filed: October 17, 2019
    Publication date: February 13, 2020
    Inventors: Robert E. DUDLEY, Panayiotis P. CONSTANTINIDES